Today’s top gainers include the company Abbott Laboratories (NYSE:ABT) which is in the industry Medical Appliances & Equipment, gaining 0.74% today. In the last week its performance is 2.85%, and -2.23% for the past quarter. Currently, Abbott Laboratories, ABT has a target price of 46.6, so today’s gain of 0.74% is a significant step towards its target price. The GAP today is therefore 0.88%.
Abbott Laboratories (NYSE:ABT), has a market cap of 62461.6, and is based in USA. Insider ownership is at 0.30%, and institutional ownership is 70.80%.
At the current price of 42.28, it has a dividend yield of 2.46%, and its target price is 46.6. This is with a profit margin of 12.00%, and total debt/equity of 0.39. Abbott Laboratories (NYSE:ABT) has a P/E of 29.75, as well as a forward P/E of 17.15.
With a current EPS of 1.42, and a forecasted EPS growth for next year at 11.89%,Abbott Laboratories (NYSE:ABT) has had a EPS growth for the past five years at -10.30%. For the next five years EPS growth is projected to be 9.40%.
Performance for the year is -12.15%. Since its IPO date on 4/6/1983, the total performance to date is -4.10%.
Volume today for Abbott Laboratories (NYSE:ABT), is 8982100, while its average volume is 11157.19. Whilst the total gain today was 0.74%, it did have a day high of -0.56%.
Volatility for this week has been at 1.24%, and 1.65% for the month. The 52-week low for Abbott Laboratories, ABT has been 18.89%, while the 52-week-high has reached -16.27%.
Looking at its return of investments, which is 7.70%, and its return on assets is 5.90%. Abbott Laboratories (NYSE:ABT) has an operating margin of 13.60%. With a sales growth of -0.20% quarter over quarter. Bearing in mind that Abbott Laboratories, ABT is in the sector Healthcare, its long-term debt/equity is 0.29, and has a current ratio of 1.5 and 1.1 for quick ratio.
So what is the value of Abbott Laboratories? Well its PEG is 3.17, and the P/S is 3.06, along with a P/B of 3.01. Meanwhile it has a p/cash of 15.79.